Main Session: Collaborative Management of Patients with Advanced Estrogen Receptor-Positive Breast Cancer

At what point does a patient become a candidate for treatment with CDK inhibitors?

Lee S. Schwartzberg, MD, FACP
West Cancer Center


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here